A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil

Epidemiology and Infection

Volumn 134, Issue 4, 2006, Pages 850-862

  Luz, P M ^a   Codeco C T ^a   Werneck, G L ^b   Struchiner, C J ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Universidade do Rio de Janeiro   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; PERTUSSIS VACCINE;

ADOLESCENT; ADULT; ARTICLE; AWARENESS; BRAZIL; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DEVELOPING COUNTRY; DISEASE TRANSMISSION; GROUPS BY AGE; HEALTH SURVEY; HUMAN; IMMUNITY; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MASS IMMUNIZATION; MATHEMATICAL MODEL; PERTUSSIS; POPULATION RESEARCH; PREDICTION; URBAN AREA; VACCINATION;

BRAZIL; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; INFANT; INFANT, NEWBORN; MASS IMMUNIZATION; MODELS, STATISTICAL; PERTUSSIS VACCINE; URBAN POPULATION; WHOOPING COUGH;

EID: 33745537949     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026880500539X     Document Type: Article

References (29)

1. Edwards KM, Decker M, Mortimer E. Pertussis vaccine. In Plotkin SA, Orenstein WA, eds. Vaccines (3rd edn). W. B. Saunders Co., Philadelphia, 1999: 293-337.
2. World Health Organization. Recommended standards for surveillance of selected vaccine-preventable diseases (www.who.int/vaccines-documents). Accessed April 2005.
3. Das P. Whooping cough makes global comeback. Lancet Infect Dis 2002; 2: 322.
4. Heininger U. Recent progress in clinical and basic pertussis research. Eur J Pediatr 2001; 160: 203-213.
5. Campins-Marti M, Cheng HK, Forsyth K, et al. Recommendations are needed for adolescent and adult pertussis immunisation: Rationale and strategies for consideration. Vaccine 2001; 20: 641-646.
6. Wirsing von Konig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2002; 2: 744-750.
7. Ntezayabo B, De Serres G, Duval B. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr Infect Dis J 2003; 22: 22-27.
8. Mooi FR, van Loo IH, King AJ. Adaptation of Bordetella pertussis to vaccination: A cause for its re-emergence? Emerg Infect Dis 2001; 7 (Suppl 3): 526-528.
9. Skowronski DM, De Serres G, MacDonald D, et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis 2002; 185: 1448-1453.
10. Secretaria Municipal de Saúde do Rio de Janeiro. Superintendência de saúde coletiva: Coordenação de programas de epidemiologia (http://www.saude.rio.rj.gov.br). Accessed November 2003.
11. Ivanoff B, Robertson SE. Pertussis: A worldwide problem. Devel Biol Standardization 1997; 89: 3-13.
12. Hethcote HW. An age-structured model for pertussis transmission. Math Biosci 1997; 145: 89-136.
13. Hethcote HW. Simulations of pertussis epidemiology in the United States: effects of adult booster vaccinations. Math Biosci 1999; 158: 47-73.
14. van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine 2004; 22: 3154-3165.
15. Hethcote HW, Horby P, McIntyre P. Using computer simulations to compare pertussis vaccination strategies in Australia. Vaccine 2004; 22: 2181-2191.
16. Instituto Brasileiro de Geografia e Estatística. Informações de saúde: Indicadores básicos de saúde (http://www.ibge.gov.br). Accessed February 2004.
17. van Boven M, de Melker HE, Schellekens JF, Kretzschmar M. Waning immunity and sub-clinical infection in an epidemic model: Implications for pertussis in The Netherlands. Math Biosci 2000; 164: 161-182.
18. Edmunds WJ, Brisson M, Melegaro A, Gay NJ. The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales. Vaccine 2002; 20: 1316-1330.
19. Guris D, Strebel PM, Tachdjian R, Bardenheier B, Wharton M, Hadler SC. Effectiveness of the pertussis vaccination program as determined by use of the screening method: United States, 1992-1994. J Infect Dis 1997; 176: 456-463.
20. Simondon F, Preziosi M, Yam A, et al. A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine 1997; 15: 1606-1612.
21. Saltelli A, Tarantola S, Campolongo F, Ratto M. Sensitivity analysis in practice: A guide to assessing scientific models, 2004. West Sussex: Wiley.
22. Simlab. Software for uncertainty and sensitivity analysis, version 2.2, 2002. Joint Research Centre of the European Commission.
23. Morris MD. Factorial sampling plans for preliminary computational experiments. Technometrics 1991; 33: 161-174.
24. Massad E, Menezes RX, Silveira PS, Ortega NR. Métodos quantitativos em medicina, 1st edn, 2004. Editora Manole Ltda, Barueri, SP.
25. Anderson RM, May RM. Infectious diseases of humans: Dynamics and control. Oxford Science Publications, 1991. Oxford University Press.
26. Guris D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: Increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999; 28: 1230-1237.
27. de Menezes RX, Ortega NR, Massad E. A Reed-Frost model taking into account uncertainties in the diagnostic of the infection. Bull Math Biol 2004; 66: 689-706.
28. Codeço CT, Luz PM, Barbosa TS, Moreira RI. Characterizing social networks of importance for the propagation of diseases transmitted through respiratory droplets. Anais do IV Congresso Brasileiro de Epidemiologia.
29. Edmunds WJ, O'Callaghan CJ, Nokes DJ. Who mixes with whom? a method to determine the contact patterns of adults that may lead to the spread of airborne infections. Proc Soc Lond Series B 1997; 264: 949-957.